The role of insulin glulisine to improve glycemic control in children with diabetes mellitus

Glulisine (Apidra(®)) is a rapid-acting human insulin analog approved for use in children with diabetes mellitus ≥4 years of age. Management of children with type 1 diabetes has seen a shift in favor of mimicking normal physiological insulin responses with multiple daily injections or continuous sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Lih, Anna, Hibbert, Emily, Wong, Tang, Girgis, Christian M, Garg, Nidhi, Carter, John N
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047962/
https://www.ncbi.nlm.nih.gov/pubmed/21437110
http://dx.doi.org/10.2147/DMSOTT.S5116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047962/
https://www.ncbi.nlm.nih.gov/pubmed/21437110
http://dx.doi.org/10.2147/DMSOTT.S5116

Ejemplares similares